Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
19.93
-0.63 (-3.06%)
At close: Dec 5, 2025, 4:00 PM EST
20.32
+0.39 (1.96%)
After-hours: Dec 5, 2025, 4:15 PM EST
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $355.38 million as of December 5, 2025. Its market cap has increased by 4,002.71% in one year.
Market Cap
355.38M
Enterprise Value
261.97M
1-Year Change
4,002.71%
Ranking
Category
Stock Price
$19.93
Market Cap Chart
Since June 16, 2020, Forte Biosciences's market cap has increased from $181.43M to $355.38M, an increase of 95.87%. That is a compound annual growth rate of 13.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 355.38M | 144.77% |
| Dec 31, 2024 | 145.19M | 386.30% |
| Dec 29, 2023 | 29.86M | 42.17% |
| Dec 30, 2022 | 21.00M | -33.49% |
| Dec 31, 2021 | 31.57M | -93.24% |
| Dec 31, 2020 | 467.16M | 157.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 905.35B |
| Johnson & Johnson | 486.47B |
| AbbVie | 403.72B |
| UnitedHealth Group | 302.45B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 251.95B |
| Abbott Laboratories | 216.05B |